Tulsa Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$753K Buy
8,723
+880
+11% +$78.2K 0.1% 89
2026
Q2
$709K Buy
7,843
+384
+5% +$32.2K 0.1% 86
2026
Q1
$597K Sell
7,459
-1,971
-21% -$162K 0.1% 88
2025
Q4
$804K Buy
+9,430
New +$774K 0.27% 55

Other funds holding EW

Tulsa Wealth Advisors's EW Position: Q3 2026 in Review

Tulsa Wealth Advisors increased its Edwards Lifesciences (EW) stake by 11% in Q3 2026, buying an estimated $78.2K and bringing the position to 8,723 shares worth $753K. The position accounts for 0.1% of the portfolio, ranked #89.

Tulsa Wealth Advisors first reported a position in EW in Q4 2025 and has held it in 4 quarters since. The position peaked at $804K in Q4 2025. 1,345 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Tulsa Wealth Advisors held 8,723 shares of Edwards Lifesciences worth $753K as of Q3 2026.
  • Tulsa Wealth Advisors bought 880 Edwards Lifesciences shares in Q3 2026, an estimated $78.2K.
  • Edwards Lifesciences made up 0.1% of Tulsa Wealth Advisors's portfolio in Q3 2026, its #89 holding.
  • Tulsa Wealth Advisors first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 4 quarters since.
  • Tulsa Wealth Advisors's Edwards Lifesciences position peaked at $804K in Q4 2025.
  • 1,345 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Tulsa Wealth Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.